About This Comparison
Our Editorial Standards
This medvi vs clinic secret provider comparison is independently researched by our editorial team. We compare telehealth services based on publicly available information including pricing, available treatments, service areas, and verified customer reviews.
Not Medical Advice: This comparison is for informational purposes only. We are not healthcare providers. Always consult with a licensed physician before starting any treatment. Read our full medical disclaimer and editorial policy.
Clinic Secret vs Medvi 2026: Medication Flexibility vs Minimum Pricing
Clinic Secret and Medvi both operate in ultra-budget tier of GLP-1 telehealth but differ in formulary breadth and pricing strategies: Clinic Secret positions as mid-tier budget platform ($247-397/month, $2,964-4,764/year) providing physician-compounded semaglutide AND tirzepatide allowing medication selection and treatment optimization through dual-GLP-1 formulary, while Medvi functions as ultra-budget platform ($199-249/month, $2,388-2,988/year) offering absolute lowest GLP-1 pricing through semaglutide-only formulary and highly streamlined operations. This comparison examines whether Clinic Secret medication flexibility justifies $600-1,800 annual premium or Medvi extreme cost minimization through formulary restriction delivers superior value for budget-conscious patients.
Platform Overview
Pricing and Cost Comparison
Medication Options and Formulary
Platform Maturity and Operational Track Record
Medical Support and Clinical Oversight
Service Model and Additional Support
Value Proposition and Cost-Benefit Analysis
How We Tested Medvi vs Clinic Secret
Our Comparison Methodology
This comparison is based on complete analysis of pricing structures, medication formularies, platform maturity, and service models from both platforms, supplemented by peer-reviewed research on GLP-1 weight loss treatment.
Clinical Evidence: Weight loss treatment recommendations reference FDA-approved GLP-1 medication information (FDA Wegovy Label), semaglutide efficacy from The New England Journal of Medicine, tirzepatide outcomes from NEJM, comparative GLP-1 efficacy from Obesity, and compounded medication quality from FDA 503B Guidelines.
Research Foundation: We analyzed peer-reviewed studies including GLP-1 medication safety from JAMA, cost-effectiveness of weight loss treatments from Health Affairs, and telehealth obesity management from JAMA Network Open.
Pricing Analysis: All pricing reflects published rates as of January 2026, verified through official platform websites.
Service Verification: Platform capabilities, medication formularies, operational history, and compounding pharmacy partnerships were evaluated through detailed review of service offerings and regulatory compliance.
We maintain independence from both platforms and receive no compensation. Our goal is to provide evidence-based comparison to help you make informed weight loss treatment decisions.
Final Verdict: Medvi vs Clinic Secret
Choose Clinic Secret if: You want medication flexibility through both semaglutide AND tirzepatide formulary allowing GLP-1 selection based on efficacy preference or tolerability, willing to pay $600-1,800/year premium ($2,964-4,764/year vs Medvi $2,388-2,988/year) for dual-medication options, prefer tirzepatide superior efficacy (20-22% weight loss vs semaglutide 15-17%), need medication alternatives if intolerant to semaglutide, value treatment optimization options through multiple GLP-1 choices, or prioritize medication flexibility over absolute minimum pricing.
Choose Medvi if: You prioritize absolute lowest GLP-1 pricing ($2,388-2,988/year) saving $600-1,800 annually vs Clinic Secret, satisfied with semaglutide-only formulary without tirzepatide access, accept medication limitation for cost savings (20-38% cheaper), don't require treatment alternatives or medication optimization flexibility, extreme cost sensitivity drives decision-making over clinical options, or make purchasing decisions based primarily on minimum price regardless of formulary restrictions.
Bottom line: Clinic Secret and Medvi represent ultra-budget tier of GLP-1 telehealth with minimal service differentiation beyond pricing and formulary breadth. Medvi operates as lowest-cost provider ($199-249/month, $2,388-2,988/year) through semaglutide-only formulary and highly streamlined operations delivering 20-38% savings vs Clinic Secret. Clinic Secret positions slightly upmarket ($247-397/month, $2,964-4,764/year) offering both semaglutide AND tirzepatide providing medication flexibility and treatment optimization options justifying $600-1,800 annual premium. Both platforms provide medication-only models without lifestyle programming, complete medical support, or established operational track records. Choice depends on whether medication formulary breadth (Clinic Secret dual-GLP-1 options) justifies $600-1,800/year premium or absolute minimum pricing (Medvi ultra-budget) prioritized accepting semaglutide-only limitation. For patients specifically wanting tirzepatide superior efficacy or medication alternatives, Clinic Secret required regardless of cost premium. For extreme cost sensitivity satisfied with semaglutide, Medvi delivers meaningful savings. Neither platform offers compelling non-price advantages—established platforms (Henry Meds, hims, Eden) provide superior operational maturity, medical support, and service quality at modestly higher costs. Budget tier competition reduces to formulary breadth vs minimum pricing trade-off.
Sources & References
Our comparisons are informed by official sources and regulatory guidelines. We encourage readers to verify information with authoritative sources.
- FDA - Semaglutide Safety InformationFDA safety information and warnings for semaglutide medications
- GoodRx - Wegovy (Semaglutide) Drug InformationGoodRx drug guide for Wegovy semaglutide: uses, dosage, side effects, and cost
- American Telemedicine Association - Why TelemedicineATA overview of telemedicine benefits and effectiveness data
- NEJM - Clinical StudyMedical research and clinical information
Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards
